Mario Sy | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Studies

CABL001J1US01_ASC4REAL-2: A real-world chronic myelogenous leukemia (CML) patient disease registry to describe patient experience and clinical outcomes among patients with CML receiving approved first or second line tyrosine kinase inhibitor (TKI) therapy

Cancer Internal Medicine Leukemia Adult Subjects